Today news
About the same in other media
Fitch affirms Glenmark Pharmaceuticals rating at 'BB'; outlook stable
Reading now: 481
Glenmark Pharmaceuticals Ltd's Long-Term Issuer Default Rating (IDR) at 'BB' following the disclosure of its intention to sell a 75% ownership in its active pharmaceutical ingredient (API) business, held under subsidiary Glenmark Life Sciences Ltd. The outlook is 'Stable', according to the international credit rating agency release today.
Read more on livemint.comAbout this in other media
US government shutdown later this year would not hurt rating: Fitch economictimes.indiatimes.com /1 year ago
Abercrombie & Fitch: When was it founded? Know is its history and journey economictimes.indiatimes.com /1 year ago
S&P 500 ends near flat; utilities drop, focus on rate outlook investing.com /1 year ago
Show more
The website fvbb.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
